Vogl T J, Müller P, Hirsch H, Philipp C, Hammerstingl R, Böttcher H, Riess H, Beuthan J, Felix R
Strahlenklinik und Poliklinik, Universitätsklinikum Rudolf Virchow, Freie Universität Berlin.
Radiologe. 1995 Mar;35(3):188-99.
In a prospective study MR-guided laser-induced thermotherapy (LITT) of liver metastases was optimized and the clinical parameters evaluated. Seventeen patients (4 women, 13 men) with a total of 29 lesions underwent LITT in 25 sessions through 1 March 1994. Twelve of them suffered from colorectal carcinomas, 5 from other primary tumors. Under local anesthesia a maximum of 5 lesions per patient were treated. For MR-guided LITT a neodymium yttrium aluminum garnet laser (Nd-YAG 1064 nm) with energy varying from 3 to 7.5 W was used. Energy and application time were defined through a computer program; they varied, dependent on the lesion size, location and consistency. To monitor the progress of LITT two special thermosensitive MR sequences (Thermo-Turbo-FLASH and FLASH-2D sequences) were individually optimized, whereby the increase in temperature correlates with an increase in signal loss. All procedures were well tolerated without significant early or late side effects. In only one patient was minimal air documentated in the pleural cavity with spontaneous resorption. Patients were dismissed without complaints after 24-h hospitalization. The control parameters of the contrast-enhanced dynamic MRI documented at optimal response a hypointense signal around the tip of the laser applicator, in accordance with laser-induced necrosis. In lesions 20 mm or smaller, nearly 100% tumor necrosis was achieved and in lesions larger than 20 mm, only 50%. Follow-up evaluation 6 months after treatment shows a significantly better response in lesions with a diameter of 20 mm or smaller, with a local tumor control rate of 66%. In lesions larger than 20 mm only a local tumor control rate of 35% could be achieved. Laser-induced thermotherapy (LITT) represents a new, minimally invasive technique for tumor destruction and a high response rate in small liver metastases.
在一项前瞻性研究中,对磁共振引导下的肝转移瘤激光诱导热疗(LITT)进行了优化,并评估了临床参数。1994年3月1日前,17例患者(4例女性,13例男性)共29个病灶接受了25次LITT治疗。其中12例患有结直肠癌,5例患有其他原发性肿瘤。在局部麻醉下,每位患者最多治疗5个病灶。对于磁共振引导下的LITT,使用了能量在3至7.5瓦之间变化的钕钇铝石榴石激光(Nd-YAG 1064 nm)。能量和照射时间通过计算机程序确定;它们根据病灶大小、位置和质地而变化。为监测LITT的进展,对两个特殊的热敏磁共振序列(热涡轮快速自旋回波序列和快速二维序列)进行了单独优化,温度升高与信号丢失增加相关。所有操作耐受性良好,无明显早期或晚期副作用。仅1例患者胸腔内记录到少量气体,可自行吸收。患者住院24小时后无不适出院。对比增强动态磁共振成像的对照参数在最佳反应时显示激光探头尖端周围有低信号,符合激光诱导的坏死。在直径20毫米或更小的病灶中,几乎实现了100%的肿瘤坏死,而在直径大于20毫米的病灶中,仅为50%。治疗后6个月的随访评估显示,直径20毫米或更小的病灶反应明显更好,局部肿瘤控制率为66%。在直径大于20毫米的病灶中,仅能实现35%的局部肿瘤控制率。激光诱导热疗(LITT)代表了一种用于肿瘤破坏的新型微创技术,对小肝转移瘤有较高的反应率。